Gyre Therapeutics (GYRE) Leases: 2019-2024
Historic Leases for Gyre Therapeutics (GYRE) over the last 5 years, with Dec 2024 value amounting to $1.8 million.
- Gyre Therapeutics' Leases rose 271.78% to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year increase of 271.78%. This contributed to the annual value of $1.8 million for FY2024, which is 271.78% up from last year.
- Per Gyre Therapeutics' latest filing, its Leases stood at $1.8 million for Q4 2024, which was down 9.10% from $2.0 million recorded in Q3 2024.
- Gyre Therapeutics' Leases' 5-year high stood at $3.1 million during Q2 2021, with a 5-year trough of $17,000 in Q1 2023.
- Over the past 3 years, Gyre Therapeutics' median Leases value was $1.2 million (recorded in 2022), while the average stood at $1.2 million.
- Per our database at Business Quant, Gyre Therapeutics' Leases tumbled by 99.24% in 2023 and then surged by 2,252.94% in 2024.
- Quarterly analysis of 5 years shows Gyre Therapeutics' Leases stood at $1.8 million in 2020, then surged by 49.78% to $2.7 million in 2021, then plummeted by 75.73% to $666,000 in 2022, then declined by 26.58% to $489,000 in 2023, then skyrocketed by 271.78% to $1.8 million in 2024.
- Its last three reported values are $1.8 million in Q4 2024, $2.0 million for Q3 2024, and $2.1 million during Q2 2024.